Hormonal contraceptives: all 330 studies that test it

Page 1 of 4. Open to participants first (27), then studies with results posted, then the rest; newest registration first within each.

• Brain and Blood Vessel Health Following Endometriosis Treatment in People With EndometriosisNot yet recruitingNCT07799246Phase 4
• A Study to Investigate the Repeat-dose Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With Ganfeborole in Female Participants of Non-childbearing PotentialRecruitingNCT07784894Phase 1
• The Influence of Plan B® on Cardiovascular Health.RecruitingNCT07759635Not applicable
• Efficacy, Safety, and Tolerability of Levonorgestrel Vaginal SystemNot yet recruitingNCT07734155Phase 3
• Rct Assessing Pregnancy - Piroxicam for Ec With LevonorgestrelNot yet recruitingNCT07449299Phase 3
• Mammogram Pretreatment With Ulipristal AcetateRecruitingNCT07434128Phase 2
• Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular ClassificationRecruitingNCT07319429Phase 2/3
• Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and VomitingNot yet recruitingNCT07124195Phase 3
• Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant UsersRecruitingNCT07083635Phase 2
• A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)RecruitingNCT06979596Phase 2
• Levonorgestrel-piroxicam Versus Ulipristal Acetate for Emergency ContraceptionRecruitingNCT06727734Phase 3
• Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell DiseaseRecruitingNCT06665997Phase 4
• Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.Not yet recruitingNCT06637189Phase 4
• Comparison of Two PPOS Models for Pituitary SuppressionNot yet recruitingNCT06304220Not applicable
• Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the EndometriumRecruitingNCT06073184Phase 2
• Etonogestrel Implants Protect Ovarian Reserve Function in Systemic Lupus ErythematosusNot yet recruitingNCT05791799Phase 2/3
• Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial HyperplasiaRecruitingNCT05675787Phase 2
• Disparities in Emergency Contraceptive Metabolism Dictate EfficacyRecruitingNCT05674513Phase 4
• Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia PatientsRecruitingNCT05565573Phase 2/3
• Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day StartRecruitingNCT05444582Phase 4
• Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-ANot yet recruitingNCT05326087Phase 3
• Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical HyperplasiaRecruitingNCT05316493Phase 2/3
• Etonogestrel Implant as Emergency ContraceptionRecruitingNCT05237141Phase 4
• Contraceptive Hormone and Reward Measurement (CHARM Study)RecruitingNCT05058872Phase 4
• Kuwa Free! - Live Free!RecruitingNCT05044962Not applicable
• Oral Contraceptive Pill Compared With Vitamin E in Women With MigraineRecruitingNCT04007874Phase 3
• A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological MalignanciesRecruitingNCT03557619Phase 1
• Phase II Study of Ovulation in Obese WomenCompletedNCT06306131Phase 2Results posted
• Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven DaysCompletedNCT05695352Phase 2Results posted
• Continuation of Subcutaneous and Intramuscular Depot Medroxyprogesterone Acetate in Post-abortion PatientsCompletedNCT05505435Phase 4Results posted
• Metabolism of 0.35mg Norethindrone vs 5mg Norethindrone AcetateCompletedNCT05294341Phase 4Results posted
• Ulipristal Acetate for Use in Early Pregnancy LossCompletedNCT05216952Phase 2Results posted
• Premature Discontinuation of Contraceptive ImplantsCompletedNCT04828824Phase 4Results posted
• A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive AgeCompletedNCT04682353Phase 1Results posted
• Evaluation of Pharmacokinetic Drug-drug Interactions Between Hormonal Contraceptives and Doravirine-containing ART Among Women Living With HIV in South AfricaCompletedNCT04669678Phase 4Results posted
• Shoulder Contraceptive Implant StudyCompletedNCT04463693Phase 4Results posted
• Breastfeeding Etonogestrel Implant StudyCompletedNCT03978598Phase 4Results posted
• Postpartum Family PlanningTerminatedNCT03844633Phase 4Results posted
• Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis TherapyCompletedNCT03819114Phase 2Results posted
• Effects of Cladribine Tablets on the PK of Microgynon®CompletedNCT03745144Phase 1Results posted
• A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046CompletedNCT03700658Phase 1Results posted
• Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual BleedingCompletedNCT03642210Phase 3Results posted
• Pharmacologic Strategies for the Etonogestrel Implant in HIV-Infected WomenCompletedNCT03282799Phase 2Results posted
• Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenCompletedNCT03271489Phase 3Results posted
• Clinical Study of Depo Provera Comparing Lay Health Workers and Clinically-trained Health WorkersCompletedNCT03255941Early Phase 1Results posted
• A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated PainCompletedNCT03213457Phase 3Results posted
• A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC ConditionsCompletedNCT03208985Phase 3Results posted
• Sayana® Press Extension StudyCompletedNCT03154125Phase 3Results posted
• Intervention to End Recurrent Unscheduled Bleeding TrialCompletedNCT03118297Phase 3Results posted
• Sayana Press UK Self-Injection StudyCompletedNCT03034057Phase 4Results posted
• Mirena Extension TrialCompletedNCT02985541Phase 3Results posted
• Labor and Delivery Implant Insertion: A Randomized Controlled TrialCompletedNCT02866643Phase 3Results posted
• Effectiveness of Orally Dosed Emergency Contraception in Obese Women - LNGCompletedNCT02863445Phase 4Results posted
• Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPACompletedNCT02859337Phase 4Results posted
• Nexplanon and Combined Oral Contraceptive (COC) Combined Use StudyCompletedNCT02852265Phase 4Results posted
• Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory CycleCompletedNCT02817464Phase 1Results posted
• Estrogen Diastolic Heart FailureTerminatedNCT02693002Phase 4Results posted
• Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)CompletedNCT02691494Phase 3Results posted
• EC PK in Women With Normal and Obese BMICompletedNCT02689804Phase 4Results posted
• Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)TerminatedNCT02668783Phase 3Results posted
• Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenCompletedNCT02654054Phase 3Results posted
• Impact of Combined Hormonal Contraceptives on UPACompletedNCT02577601Phase 4Results posted
• Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl EstradiolCompletedNCT02533427Phase 1Results posted
• Protease Inhibitors and Combined Oral Contraceptive Pharmacokinetics and PharmacodynamicsTerminatedNCT02531321Phase 4Results posted
• Depo Provera Self-Administration Study: Putting a Patient-Centered Practice to the Test at Planned ParenthoodCompletedNCT02509767Phase 4Results posted
• Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local ImmunityCompletedNCT02432404Phase 4Results posted
• Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in MenCompletedNCT02432261Phase 1Results posted
• PK Study of Rifampicin Interactions With DMPA and Efavirenz in TBCompletedNCT02412436Phase 2Results posted
• Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System UsersCompletedNCT02362373Phase 4Results posted
• Impact of Hormonal Contraception on HIV Acquisition and Transmission RiskCompletedNCT02357368Phase 4Results posted
• Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive ImplantCompletedNCT02353247Not applicableResults posted
• Belatacept 3 Month Post Transplant Conversion StudyCompletedNCT02213068Phase 4Results posted
• Bay98-7196, Dose Finding / POC StudyCompletedNCT02203331Phase 2Results posted
• RAPID EC - Rct Assessing Pregnancy With Intrauterine Devices for ECCompletedNCT02175030Phase 4Results posted
• A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With LeiomyomasCompletedNCT02147197Phase 3Results posted
• A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With LeiomyomasCompletedNCT02147158Phase 3Results posted
• HSG and Tubal Patency StudyCompletedNCT02146248Not applicableResults posted
• The Impact of Contraception on Postpartum Weight LossCompletedNCT02144259Not applicableResults posted
• LNG-IUS at 2 Weeks PostpartumCompletedNCT02121067Phase 4Results posted
• Evaluate the Effect of Ethinyl Estradiol/Norgestimate on the Pharmacokinetics of Lomitapide in Healthy Female SubjectsCompletedNCT02080468Phase 1Results posted
• BLIS - Breastfeeding Levonorgestrel IUD StudyCompletedNCT01990703Phase 4Results posted
• Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral ContraceptiveTerminatedNCT01963403Phase 4Results posted
• Effect of Pre-operative Depo Medroxyprogesterone Acetate on Serum Anti-mullerian Hormone Level After Laparoscopic Ovarian Cystectomy of EndometriomasCompletedNCT01791413Phase 1/2Results posted
• Immediate vs. Delayed Postpartum Etonogestrel ImplantCompletedNCT01767285Phase 4Results posted
• A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012)CompletedNCT01709318Phase 2Results posted
• The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone ContraceptionCompletedNCT01667978Not applicableResults posted
• PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine LeiomyomataCompletedNCT01629563Phase 3Results posted
• Study to Evaluate Pharmacokinetics Profile, Wearability, and Safety of 2 Progestin-Only PatchesCompletedNCT01623466Phase 1/2Results posted
• Drug-drug Interaction of BI 201335 and MicrogynonCompletedNCT01570244Phase 1Results posted
• Study of the Use of a Contraceptive Vaginal Ring (NuvaRing) in Normal Daily Practice in Indian Women (P07733)CompletedNCT01490190Phase 4Results posted
• Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and DepressionCompletedNCT01463202Phase 4Results posted
• Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent SubjectsCompletedNCT01461824Phase 3Results posted
• Drug-drug Interaction of Empagliflozin (BI 10773) and MicrogynonCompletedNCT01328184Phase 1Results posted
• Long-Acting Reversible ContraceptionCompletedNCT01299116Phase 4Results posted
• NuvaRing vs. Oral Contraceptive Pills (OCP) for In-Vitro Fertilization (IVF) Pre-treatmentTerminatedNCT01298128Not applicableResults posted
• Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected WomenCompletedNCT01296152Phase 2Results posted
• A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450)CompletedNCT01277211Phase 3Results posted
• Evaluation of Pharmacodynamic Effects on Ovulation and Cycle ControlCompletedNCT01250210Phase 2Results posted
• Study of Immune Cell Changes in the Genital Tract 2 Months After Initiation of an IUD for ContraceptionCompletedNCT01240811Not applicableResults posted
• Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fed ConditionsCompletedNCT01181726Phase 1Results posted

← Hormonal contraceptives overview